You are currently viewing Systemaic treatment of the side branch in a bifurcation lesion with a new drug eluting balloon: the DEBSIDE study. 12 months results

Systemaic treatment of the side branch in a bifurcation lesion with a new drug eluting balloon: the DEBSIDE study. 12 months results

EBC - ON DEMAND

Systemaic treatment of the side branch in a bifurcation lesion with a new drug eluting balloon: the DEBSIDE study. 12 months results

European Bifurcation Club 2015 – EBC 2015 – Athens, Greece

News (2)

Systemaic treatment of the side branch in a bifurcation lesion with a new drug eluting balloon: the DEBSIDE study. 12 months results

Author: Eduardo APTECAR, Clinique les Fontaines, MELUN, FRANCE

 

CONCLUSION

  • Systematic final inflation of a drug-eluting balloon (DANUBIO) in the side branch after placement of a drug-eluting dedicated stent (Nile PAX) in the main vessel for the treatment of bifurcation lesions resulted in a very low late lumen loss (-0.04±0.34mm) and restenosis rate (2.0%) at the side branch ostium.
  • Although suboptimal angiographic results obtained in the main branch were observed, they did not impact the good clinical (TLR in SB = 2.0%) and angiographic results in the side branch.
  • Additional and complementary studies with larger populations, combining newer-generation limus-eluting stents, which could enable beper results on the main branch, along with the DANUBIO drug-eluting balloon would certainly be of especial interest.
  • In this context, a sirolimus-eluting version of the Nile dedicated stent platform is currently being developed.

 

Download here

Leave a Reply